DM

Showing posts with label Living. Show all posts
Showing posts with label Living. Show all posts

Sunday, August 18, 2013

Dad Dies After Drinking Poison in Assisted Living

George McAfee, a former running back for the Chicago Bears who developed dementia in his twilight years, died an excruciating and humiliating death in 2009 while in the care of an Atlanta assisted-living facility.

The pro-football Hall of Famer wandered unsupervised into a cleaning room and drank from a bottle of industrial-strength detergent. The caustic chemical burned his lips, esophagus and lungs before he died in the hospital, according to his family, which settled with the Emeritus Corporation, the company that ran the facility and took responsibility for his death.

When caregivers found McAfee, his lips were black and his face looked like a "horror show death mask," according to his daughter, Cheryl Morgan, 66, of Stone Mountain, Ga.

"It was horrible, horrible," she told ABCNews.com. "I cannot begin to tell you how horrific it was. We just hope he wasn't conscious."

Now, filmmaker A.C. Thompson of ProPublica, in collaboration with reporter Jonathan Jones and PBS' "Frontline," has taken a critical look at the for-profit world of assisted-living facilities. In addition to quasi-independent care, the facilities offer so-called "memory units" for families who want a safe and home-like environment for their loved ones who are suffering from dementia and Alzheimer's disease.

The facilities, sometimes with spiral staircases and lush grounds, are loosely regulated, depending on the state, and often don't have a full-time nurse on duty, according to the "Frontline" report, in contrast to nursing homes, which are federally funded and, therefore, under tougher scrutiny.

"Life and Death in Assisted Living" will air tonight at 10 p.m. ET.

"I realized that, in some ways, this is a secret world and people don't understand what's going on and the rules governing it," Thompson told ABCNews.com.

Conditions are difficult and workers are paid minimum wage, according to Thompson, who interviewed staff workers and elder care advocates.

"There is a high burn-out factor and people often don't last," said Thompson. "You get a revolving cast of caregivers.

For a lot of people without dementia, these facilities are great," he said. "They don't necessarily need a nurse to tend to them around the clock and they don't need an institutional setting.

"We met lots of compassionate, considerate, smart caregivers," he added. "My concern is that it's a loosely regulated industry and things can go traumatically wrong. The industry has an incredible emphasis on sales and revenue -- and making as much money as possible."

Researching consumer lawsuits and complaints in numerous facilities nationwide that led to injuries and death, Thompson cited inadequate staffing ratios, limited training and policies that put profit over patients' well-being.

One staffer said in the film that training consists of one eight-hour session on how to feed and talk to dementia patients.

Thompson examined numerous public files on assaults between residents, sexual assaults by caregivers and patients who went missing. One, according to the documentary, was never found.

Thompson alleged these units are marketing tools and "money makers."

The documentary focuses on one of the industry's leaders, Seattle-based Emeritus Corporation, whose advertising slogan is, "Our family is committed to yours."

Emeritus is the largest company in the assisted living business. It is publicly traded, with $1.6 billion in revenues a year, and is responsible for 42,000 residents at 480 facilities around the country.

"I adamantly disagree that we put profits ahead of service care," Granger Cobb, president and CEO of Emeritus, told ABCNews.com.

"Senior living is a highly competitive industry," he said. "It's a very emotional time when a family considers many assisted living options and they reach out to friends and family and physicians and clergymen and ask for referrals.

Having a strong reputation is critical. Otherwise, we don't last very long. I don't think a company would ever sacrifice that reputation and customer satisfaction for some short-term gain on bottom line."

But McAfee's family sued Emeritus, which settled out of court. Facility records eventually revealed that for a half hour no one was on duty in the wing where McAfee found the cleaning fluid.

Cobb acknowledged an Emeritus staff member failed to lock the cabinet -- "a failure on our part."

"George McAfee was an absolute tragic accident that was horrific and the community was devastated," he said. "We sincerely regret the pain and trauma they experienced. … There has never been a similar accident in 20 years since we were founded."

Thompson's year-long investigation also uncovered the case of a Texas woman who froze to death on Christmas day in 2004. Her family sued Emeritus and settled confidentially. He also found several cases of patients falling to their deaths at Emeritus facilities.

"When dealing with this many residents, particularly a population that can have unpredictable behavior or is frail or high-risk to begin with, we will have a situation with them from time to time," he said.

In the next 15 years, the number of Americans who are 70 and older will grow by 1 million annually, Cobb noted in the film.

"Memory units are an ideal choice for those who are memory impaired but who don't have intense medical needs," he said. "The environment feels more normal and home-like to them."

"Frontline" noted that because of their age, most residents in this age group are on multiple medications -- often 10 to 15 a day -- and said lack of medical services and understaffing can lead to mistakes.

The film cited one incident when only one employee was on staff at night.

But Emeritus' Cobb said that, "generally speaking," company facilities have at least three staff members on a night -- two caregivers and a med tech.

In the documentary, former Emeritus staff members and nurses at numerous facilities described a "back-door" policy, saying that they were encouraged not to let patients leave these units for nursing homes to keep beds full.

"Generally, families want to keep their loved ones with us as long as possible and defer moving to skilled nursing," said Cobb. "If a resident requires skilled nursing, we work with the family to arrange as quickly and smoothly as possible."

McAfee was at several other facilities before coming to Cypress Gardens near his daughter, Morgan, in Georgia in 2006. The fee was $4,000 a month -- "a lot of money," she said.

The family thought they had "struck gold" -- a far cry from the sterile corridors of a nursing home where they saw patients sit listless in wheelchairs.

But when Emeritus took over the facility shortly thereafter, "it went down from there," said Morgan, alleging his sheets were never changed, the room and he were rarely cleaned and he "looked like a dirty old man."

At first, her father had regular caregivers who knew his tendency to be obstinate and to wander. But soon, Emeritus began to rotate staff, according to Morgan.

"He was a wanderer and he couldn't sleep," she said.

You are using an outdated version of Internet Explorer. Please click here to upgrade your browser in order to comment.

View the original article here

Sunday, July 7, 2013

New Technique Developed To Track Cell Interactions In Living Bodies

Main Category: Cancer / Oncology
Also Included In: Biology / Biochemistry
Article Date: 08 May 2013 - 1:00 PDT Current ratings for:
New Technique Developed To Track Cell Interactions In Living Bodies
not yet ratednot yet rated
Researchers at Stanford University School of Medicine have developed a new technique to see how different types of cells interact in a living mouse. The process uses light-emitting proteins that glow when two types of cells come close together.

Using the technique, the team was able to pinpoint where in the body metastatic cancer cells ended up after they broke off from an initial tumor site, using readily available lab reagents. The team chose chemicals that are easily available in most life sciences laboratories because they wanted to develop a technique that could be widely used.

The study was published online in the Proceedings of the National Academy of Sciences.

Until now, the best way to see cells interacting inside a living animal or person was to implant a microscope. But predicting all the places metastatic cancer cells will proliferate is nearly impossible. "There are currently no great ways to look at early metastasis, where metastases are finding their micro-environments and setting up shop," said Mark Sellmyer, MD, PhD, the study's lead author, who developed the technique as a graduate student working jointly for Christopher Contag, PhD, professor of pediatrics and of microbiology and immunology, and Tom Wandless, PhD, associate professor of chemical and systems biology.

Sellmyer, who begins a research residency in radiology at the University of Pennsylvania this summer, worked closely with Jennifer Prescher, PhD, a former postdoctoral scholar in Contag's lab who is now an assistant professor at the University of California-Irvine. "I think it really expands our capabilities, expands the tool box," Prescher said. "We're always beholden to the tools available for us in terms of what we can observe. Any time we have a new vantage point - a new technology - it can open doors to understanding new aspects of biology."

Sellmyer and Prescher genetically altered immune cells and cancer cells - what they call activator and reporter cells, respectively - so the cells would produce two different enzymes. The activator immune cells created the enzyme B-galactosidase, which can convert a common biological probe called a "caged luciferin" into luciferin, a molecule naturally found in animals like fireflies. The reporter cancer cells created the enzyme luciferase, which splits the luciferin molecule in a chemical reaction that emits light.

After demonstrating the process could work in a cell culture in a petri dish, they used the same method in living mice. The mice were implanted with genetically altered bone marrow cells that generated activator immune cells. An experimental group of 10 mice had tumors made of cancer cells genetically altered to serve as reporters implanted into their abdomens. For comparison, a control group of four additional mice were implanted with unaltered bone marrow cells. After several weeks, the researchers injected a compound that would be converted to light-emitting luciferin.

The researchers could easily see where populations of immune cells got close to metastatic cancer cell populations because those parts of the mouse body would glow and take a picture of the pattern of light emitted by the mouse's body. Among other metastasis sites, researchers were surprised to find that in several mice, small populations of cancer cells had started to grow in their noses and just under their lower jaws.

Currently, the technique can't be used in people, but the researchers hope it will be used to study a variety of cell interactions in laboratory mice. Contag is planning to use the technique to study how immune cells migrate to sites of infection. Cell-cell communication is important for a variety of biological processes," he said. "Knowing the proximity of one cell type to another in the context of the living tissue is key for understanding biology."

The technique requires a minimum population of 1,000 cells for both the activator and reporter cells to work. Prescher is working on improving the precision of the method so that smaller populations with fewer cells can be tracked.

Both Contag and Wandless noted that Sellmyer's and Prescher's interdisciplinary approach was key to developing the technique. "Their training in biology allowed them to identify an important problem in the area of in vivo imaging, and their ability to incorporate chemistry allowed Mark and Jenn to design and develop a new technique that would be out-of-reach to the majority of classical biology labs," Wandless said.

Article adapted by Medical News Today from original press release. Click 'references' tab above for source.
Visit our cancer / oncology section for the latest news on this subject. Other Stanford authors of the study include postdoctoral scholar Laura Bronsart, PhD, and visiting scholar Hiroshi Imoto, PhD.

The study was supported by the National Institutes of Health (grants GM073046 and P50CA114747), the NIH Medical Scientist Training Program and the Susan G. Komen Foundation.

Stanford University Medical Center

Please use one of the following formats to cite this article in your essay, paper or report:

MLA

Stanford University Medical Center. "New Technique Developed To Track Cell Interactions In Living Bodies." Medical News Today. MediLexicon, Intl., 8 May. 2013. Web.
13 May. 2013. APA

Please note: If no author information is provided, the source is cited instead.


'New Technique Developed To Track Cell Interactions In Living Bodies'

Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.

If you write about specific medications or operations, please do not name health care professionals by name.

All opinions are moderated before being included (to stop spam)

Contact Our News Editors

For any corrections of factual information, or to contact the editors please use our feedback form.

Please send any medical news or health news press releases to:

Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.



View the original article here